![]() |
|
|
| Support: References |
| Following are some of the key references to the
proprietary Shelhigh
No-React® tissue treatment process and Shelhigh surgical devices in
clinical practice. Full articles may be obtained
on-line via the links provided below, or at
Pubmed.gov.
No-React Technology
Abolhoda A, Yu S, Oyarzun JR, Allen KR, McCormick JR, Han S, Kemp FW, Bogden JD, Lu Q, Gabbay S. No-React Detoxification Process: A Superior Anticalcification Method for Bioprostheses. Ann Thorac Surg 1996; 62:1724-30` Abolhoda A, Yu S, Oyarzun JR, McCormick JR, Bogden JD, Gabbay S. Calcification of Bovine Pericaridum: Glutaraldehyde Versus No-React Biomodification. Ann Thorac Surg 1996; 62:169-74
Aortic Root Replacement
Carrel TP, Berdat P, Englberger L, Eckstein F, Immer F, Seiler C, Beat K, Schmidli J. Aortic Root Replacment with a New Stentless Aortic Valve Xenograft Conduit: Preliminary Homodynamic and Clinical Results. The journal of Heart Valve Disease 2003; 12:752-757 Kincaid EH, Riley RD, Hines MH, Hammon JW, Kon ND. Anterior Leaflet Augmentation for Ischemic Mitral Regurgitation. Ann Thorac Surg 2004; 78:564-8
Pulmonic Valve Performance
Marianeschi SM, Iacina GM, Seddio F, Abella RF, Condoluci C, Cipriani A, Iorio FS, Gabbay S, Mercellitti CF. Shelhigh No-React Porcine Pulmonic Valve Conduit: A New Alternative to the Homograft. Ann Thorac Surg 2001; 71:619-23 Eigel P, Larsen AL, Ingen GV. Pulmonary valve replacement for pulmonary thrombus formation after previous aortic valve replacement, Guillain-Barre syndrome and enterococcal sepsis. Interactive CardioVascular and Thoracic Surgery 4 (2005) 521-522.
Resistance to Infection
Siniawski H. Active Infective Aortic Valve Endocarditis with Infection Extension: Clinical Features, Perioperative Echocardiographic Findings and Results of Surgical Treatment. Steinkopff Verlag, Darmstadt. 2006 ISBN 3-7985-1521-2 Musci M, Siniawski H, Knosalla C, Grauhan O, Weng Y, Pasic M, Meyer R, Hetzer R. Early and Mid-term Results of the Shelhigh Stentless Bioprosthesis in Patients with Active Infective Endocarditis. Clin Res Cardiol 95:247-253 (2006) Siniawski H, Grauhan O, Hofmann M, Pasic M, Weng Y, Yankah C, Lehmkuhl H, Hetzer R. Factors Influencing the Results of Double-Valve Surgery in Patients with Fulminant Endocarditis: The Importance of Valve Selection. The Heart Surgery Forum #2004-10757 (5) (Epub September 2004) doi: 10.1532/HSF98.20041075 Siniawski H, Grauhan O, Hofmann M, Pasic M, Weng Y, Yankah C, Lehmkuhl H, Hetzer R. Aortic root abscess and secondary infective mitral valve disease: results of surgical endocarditis treatment. European Journal of Cardio-Thoracic Surgery 27 (2005) 434-440 Siniawski H, Lehmkuhl H, Weng Y, Pasic M, Yankah C, Hoffmann M, Behnke I, Hetzer R. Stentless Aortic Valves as an Alternative to Homografts for Valve Replacment in Active Infective Endocarditis Complicated by Ring Abscess. Ann Thorac Surg 2003; 75:803-8
Conduit Performance
Spaggiari L, Galetta D, Veronesi G, Leo F, Gaspiarri R, Petrella F, Borri A, Pelosi G, Venturino M. Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis: Preliminary Results. Journal of Thorac and Cardiovasc Surg 2006; 131:491-2 Gober V, Berdat P, Pavlovic M, Pfammatter JP, Carrel TP. Adverse Mid-Term Outcome Following RVOT Reconstruction Using Contegra Valved Bovine Jugular Vein. Society of Thoracic Surgeons 0003-4975/05 Reddy SLC, Pillai J, Mitchell Leslie, Naik S, Dark J, Hasan A, Ledingham S, Clark SC. First Report of the No-React Bovine Internal Mammary Artery Performance and Patency. The Heart Surgery Forum # 2004-10807 (5), 2004 (Epub Spetember 2004) doi:10.1532/HSF98.20041080 Shebani O, McGuirk S, Baghai M, Stickley J, De Giovanni JV, Bu’Lock FA, Barron DJ, Brawn WJ. Right Ventricular Outflow Tract Reconstruction Using Contegra® Valved Conduit: natural history and conduit performance under pressure. European Journal of Cardio Thoracic Surgery 29 (2006) 397-405 |
|
|
Shelhigh products may be sold only upon the written prescription of a physician. Not all Shelhigh products are for sale in the United States; consult your Shelhigh distributor or Shelhigh Corporate Office for more information. |
|
|